JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BVAL
3801
DELISTED
Brand Value ETF
BVAL
| $630K | ﹤0.01% |
39,700
| – | – |
2017 Q2
2 quarters
|
|
|
ISEE
3802
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $629K | ﹤0.01% |
201,762
+169,176
| +519% | +$476K |
2013 Q4
16 quarters
|
|
3803
First Trust STOXX European Select Dividend Income Fund
FDD
$865M
| $626K | ﹤0.01% |
45,570
-44,803
| -50% | -$609K |
2015 Q3
9 quarters
|
|
3804
White Mountains Insurance
WTM
$4.8B
| $624K | ﹤0.01% |
+734
| New | +$642K |
2017 Q4
0 quarters
|
|
3805
Marcus & Millichap
MMI
$1.1B
| $622K | ﹤0.01% |
+19,079
| New | +$568K |
2017 Q4
0 quarters
|
|
|
IMVP
3806
Invesco India ETF
IMVP
$93.7M
| $619K | ﹤0.01% |
23,439
-94,755
| -80% | -$2.39M |
2013 Q2
18 quarters
|
|
3807
Zumiez
ZUMZ
$207M
| $619K | ﹤0.01% |
29,706
+23,501
| +379% | +$450K |
2016 Q4
4 quarters
|
|
|
DS
3808
DELISTED
Drive Shack Inc.
DS
| $619K | ﹤0.01% |
+111,990
| New | +$532K |
2017 Q4
0 quarters
|
|
3809
German American Bancorp
GABC
$1.83B
| $618K | ﹤0.01% |
17,476
-11,663
| -40% | -$427K |
2013 Q2
18 quarters
|
|
3810
PUT
Archer Daniels Midland
ADM
$38.3B
| $617K | ﹤0.01% |
15,400
| – | – |
2017 Q1
3 quarters
|
|
3811
State Street SPDR S&P Insurance ETF
KIE
$542M
| $617K | ﹤0.01% |
20,108
+785
| +4% | +$24.1K |
2017 Q2
2 quarters
|
|
3812
Daktronics
DAKT
$847M
| $613K | ﹤0.01% |
67,052
+8,658
| +15% | +$85.5K |
2016 Q3
5 quarters
|
|
3813
Oxford Square Capital
OXSQ
$139M
| $613K | ﹤0.01% |
106,597
-189,196
| -64% | -$1.18M |
2015 Q4
8 quarters
|
|
3814
Mammoth Energy Services
TUSK
$137M
| $612K | ﹤0.01% |
31,165
+13,665
| +78% | +$249K |
2016 Q4
4 quarters
|
|
3815
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.27B
| $611K | ﹤0.01% |
10,070
-64
| -0.6% | -$3.76K |
2015 Q3
9 quarters
|
|
3816
iShares MSCI Pacific ex Japan ETF
EPP
$2.2B
| $608K | ﹤0.01% |
12,725
-4,433
| -26% | -$209K |
2013 Q2
18 quarters
|
|
3817
Forestar Group
FOR
$1.33B
| $604K | ﹤0.01% |
27,464
-2,111,405
| -99% | -$41M |
2013 Q2
18 quarters
|
|
3818
Innovative Industrial Properties
IIPR
$1.41B
| $604K | ﹤0.01% |
18,699
+18,099
| +3,017% | +$369K |
2017 Q3
1 quarter
|
|
|
CETV
3819
DELISTED
Central European Media Enterprises Ltd
CETV
| $604K | ﹤0.01% |
129,793
+31,021
| +31% | +$142K |
2014 Q4
12 quarters
|
|
|
AIG.WS
3820
DELISTED
American International Group, Inc.
AIG.WS
| – | – |
0
| – | – |
2015 Q4
8 quarters
|
|
|
PZN
3821
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $600K | ﹤0.01% |
56,285
+52,975
| +1,600% | +$594K |
2017 Q3
1 quarter
|
|
3822
Vitamin Cottage Natural Grocers
NGVC
$702M
| $599K | ﹤0.01% |
67,138
+30,532
| +83% | +$201K |
2017 Q3
1 quarter
|
|
3823
PUT
Western Digital
WDC
$167B
| $596K | ﹤0.01% |
+9,923
| New | +$639K |
2017 Q4
0 quarters
|
|
|
ARRY
3824
DELISTED
Array Biopharma Inc
ARRY
| $595K | ﹤0.01% |
46,475
-233,289
| -83% | -$2.65M |
2017 Q3
1 quarter
|
|
3825
DHI Group
DHX
$207M
| $589K | ﹤0.01% |
309,970
+27,884
| +10% | +$57.8K |
2016 Q3
5 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.